Resources

Key takeaways for healthcare: Mary Meeker’s 2017 Internet Trends Report

Read More

International Clinical Trials Day 2017

Read More

Roundtable podcast – ePatient insights on hepatitis C

Read More

Are EMRs the future of clinical trial recruitment?

Read More

eConsent comes of age

Read More

Industry warming to eConsent

Read More

21st Century Cures Act approved with overwhelming support

Read More

Market-specific considerations for clinical trial online advertising

Read More

Closing the gap between patients and pharma

Read More

Advertising clinical trials online. Why, How, What, Where? And what to avoid!

Read More

mHealth rides high but privacy concerns remain

Read More

Only a hip-hooray for HIPAA

Read More

Engaging the hard to reach

Read More

Clustering around patients

Read More

European data protection: the future

Read More

The Duchenne template for patient input

Read More

FDA guidelines called for to encourage use of new tech in clinical research

Read More

CROs capable partners in trial design?

Read More

The problem with outcome switching in clinical trials

Read More

Time to stop just talking about innovation

Read More

Getting a head start on cancer

Read More

Tudor Reilly Health discusses new European data protection laws in International Clinical Trials

Read More

Fighting fire with fire

Read More

All systems Go for Google

Read More

Digital information to the fore

Read More

Consumer tech showcase sets stage for inventive year in digital health

Read More

Tudor Reilly Health features in new book advocating for patient-driven R&D

Read More

Genetic find and replace

Read More

TEDMED goes back to basics

Read More

With a ‘post-antibiotic era’ looming-communication is key

Read More

Games aren't just for fun

Read More

Tudor Reilly Health presents at Clinical Monitoring and Patient Recruitment & Retention Summit

Read More

A research tool in your pocket

Read More

Smart meds join the internet of things

Read More

Google’s biggest moon shot

Read More

Minority report

Read More

Paradox of rare disease drug development

Read More

TRH to partner with The CATS Foundation

Read More

Honouring the code

Read More

BlackBerry’s lessons for Fitbit

Read More

Mary Meeker’s mobile internet trends

Read More

Pro bono support package with TRH

Read More

Rewards for good behaviour

Read More

Mobilegeddon

Read More

Open-source people

Read More

Genomic portraits of two nations

Read More

Speaking plainly

Read More

Third time lucky

Read More

Tudor Reilly Health presents at 2nd Annual Operational Excellence in Clinical Trials Summit

Read More

Apple and the future of smartwatches

Read More

Ideate to innovate

Read More

Tudor Reilly Health presents at 7th Annual Patient Recruitment and Retention Summit

Read More

Why orphan approvals defy gravity

Read More

Genomics project to revolutionise medicine

Read More

Making clinical trials inclusive

Read More

Ending Duchenne?

Read More

Accelerating access

Read More

Hepatitis C News reaches 65,000 unique visitors

Read More

Healthcare, online

Read More

Technology's future in healthcare

Read More

Medical innovation, or recklessness?

Read More

Internet addiction: no longer a virtual reality?

Read More

Checking in with the brain's GPS

Read More

Laughter in the courtroom!

Read More

TEDMED 2014 innovations empower patients

Read More

TEDMED 2014: Unlocking imagination in service of health and medicine

Read More

Digital privacy: are we sharing too much?

Read More

Should early-stage experimental drugs be used ahead of approval?

Read More

‘Appy as Larry

Read More

Healthy lifestyle advice - is it time for governments to butt out?

Read More

Tudor Reilly Health joins Britain's most ambitious enterprises

Read More

Years in the making, social media guidance finally released

Read More

Costing lives – the promise and the price of new drug treatments

Read More

An elephant never forgets – but does the internet?

Read More

Digital tools provide insights into the rare

Read More

Why ownership is irrelevant in Pfizer bid for AstraZeneca

Read More

'Vampire mice' turn back the clocks

Read More

The direct-to-doctor app

Read More

How much is six months worth?

Read More

Controversy flares as Condoleezza Rice joins Dropbox board

Read More

Who’s afraid of Cochrane?

Read More

Big Pharma, Big Plans

Read More

Tudor Reilly Health supports Empower: Access to Medicine initiative

Read More

Personal information - public knowledge?

Read More

Tudor Reilly Health presents at Operational Excellence in Clinical Trials Summit

Read More

Nuts and bolts of digital patient recruitment

Read More

Tudor Reilly Health at the Clinical Outsourcing & Partnering World Conference 2014

Read More

Tudor Reilly Health moves to Tech City

Read More

Rare Disease Day 2014

Read More

Tapping the brain’s natural pharmacy

Read More

Troubled Twitter hopes for a brighter future

Read More

Facebook ad grab

Read More

Lean start-ups – build, test, adjust their way to success

Read More

Out in the cold - Big pharma and social media

Read More

New treatments set to awaken the sleeping pharmaceutical giants

Read More

Consumer Electronics Show 2014 – Wearing your heart (rate) on your sleeve

Read More

23andMe suspends health-related genetic tests

Read More

Big data: A challenge and an opportunity

Read More

Testing times for genome service 23andMe

Read More

The next generation: New technologies that could change the way we live

Read More

How big data can revolutionise patient recruitment to clinical trials

Read More

Indian ruling cuts hundreds of clinical trials

Read More

UK’s digital divide impacts upon the individual and the collective

Read More

Tudor Reilly Health in International Clinical Trials

Read More

Wanted: 100,000 volunteers to share their genetic information online

Read More

Google Plus aiming to revolutionise photography

Read More

Modern science must act against complacency

Read More

Tudor Reilly Health at the Festival of Marketing 2013

Read More

Walking could save 37,000 lives

Read More

Global digital privacy under the spotlight

Read More

Google's Moon Shots

Read More

Tudor Reilly Health launches online patient forum for hepatitis C in partnership with HealthUnlocked

Read More

Life as an intern at Tudor Reilly Health

Read More

Doctors not so disconnected after all

Read More

Big Brother healthcare?

Read More

Tudor Reilly Health shortlisted for the Digital Impact Awards

Read More

Miniature brain opens research avenues

Read More

App-y ever after

Read More

Tudor Reilly Health – a top 25 health consultancy

Read More

Health and fitness apps make their mark as usage increases

Read More

Minding our language 2.0

Read More

Tudor Reilly Health a finalist at the PM Society Digital Media Awards

Read More

A digital union

Read More

Doctor disconnect

Read More

Roundtable podcast – ePatient insights on hepatitis C

Read More

Perceptions of the patient

Read More

Tudor Reilly Health – a top 50 digital agency

Read More

Three-quarters of patients not told about clinical trials

Read More

Webcast roundtable: ePatient Insights on hepatitis C

Read More

Hold the fish: new study links fish oils to prostate cancer

Read More

Getting to grips with big data

Read More

The revolution will not be televised

Read More

Knights of healthcare

Read More

Catalysing open science

Read More

Google set to take a bite out of Apple

Read More

Tudor Reilly Health supports mental health awareness training for GP practices

Read More

Ireland to introduce plain cigarette packaging – triumph or disaster?

Read More

International Clinical Trials Day

Read More

Is there a gene for genius?

Read More

The Patient View?

Read More

H7N9 bird flu – the scientists are taking it seriously, but is anyone else?

Read More

Partnerships in Clinical Trials – Orlando

Read More

Unraveling our fascination with the double helix

Read More

Tudor Reilly Health MD shortlisted for the First Women Awards

Read More

The Wales Gene Park

Read More

Tudor Reilly in Florida

Read More

H1N1 data: a step towards transparency?

Read More

Reactions to job losses at AstraZeneca

Read More

Regulatory innovation

Read More

Quis custodiet ipsos custodies?

Read More

Tudor Reilly Health roundtable at the Royal Society of Medicine

Read More

Delay preferable to error?

Read More

Pharma is cleaning up its act

Read More

Bad Pharma - or Bad Regulators?

Read More

Leading public health official warns of viral apocalypse

Read More

Picking Pascal’s protégé

Read More

Stroke can hit at any age – Know the signs

Read More

Tudor Reilly Health wins international contract in biosimilars

Read More

Pharma predictions for 2013

Read More

Tudor Reilly’s highlights of 2012

Read More

Plotting the DNA map

Read More

Tudor Reilly rising star is one of PR Week’s 29 under 29

Read More

Clinical trial data - Free at last?

Read More

Escalating polypharmacy and the prescribing cascade

Read More

Fakebook?

Read More

The future for mental illness and diagnosis

Read More

Clinical trial hotspots

Read More

The Hannah Crown Affair

Read More

World Mental Health Day

Read More

Light relief for the UK bioscience community

Read More

Mental health - the stigma that persists

Read More

BBC’s Jane Hughes speaks at Tudor Reilly Health roundtable

Read More

ZSL Stampede for AKU

Read More

The value of junk

Read More

We are all investors now

Read More

Minding our language

Read More

Failure a necessary part of Alzheimer's success

Read More

Tudor Reilly announces healthcare heroes of the year

Read More

Olympic Twitter twits

Read More

Progress in hunt for Alzheimer’s cure

Read More

Tudor Reilly in PR Week’s Top 25 Healthcare Agencies

Read More

Universal healthcare

Read More

The medical social network

Read More

Playing catch-up: biosimilars policy struggles to stay ahead of the technological developments

Read More

Breast cancer mapped out

Read More

The Obesity Olympics?

Read More

Healthcare for all, not just the many

Read More

Flying solo

Read More

Glaxo and China: Yin and Yang?

Read More

United pledge to combat diseases of ‘neglected people’

Read More

Riddling Alzheimer’s disease

Read More

Tudor Reilly wins specialty pharmaceutical contract

Read More